Long-term safety of a silicone tube eye implant
Part of Eyes & vision clinical trials.
This study follows up with people who have previously received a special silicone tube implant in their eye to see how they are doing over time. It aims to check the long-term safety and how well the implant is working.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have already been treated with the suprachoroidal silicone tube shunt (an implant in your eye).
- You are willing and able to take part in this follow-up study.
- You can understand and sign a consent form agreeing to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a glaucoma drainage device approach to see which one better prevents loss of corneal cells after surgery. You may benefit by receiving close monitoring around the time of glaucoma surgery and helping doctors improve surgical choices.
This trial compares two types of glaucoma drainage devices (Baerveldt and Paul) in people whose glaucoma is not well controlled with eye drops. It aims to find which device works better at lowering eye pressure and is safer.
This study follows patients over time to see how well different glaucoma treatments (medications, laser, or surgery) work. It may help doctors learn which treatments are best for managing glaucoma and high eye pressure.
This study is checking how the Hydrus implant (a tiny device for glaucoma) is doing more than 8 years after it was placed. It aims to see if the eye pressure is still controlled and if the eye is healthy. If you were in one of the earlier Hydrus studies in Mainz and had the implant with or without cataract surgery, this follow-up may be for you.
This trial is checking how well a combined eye surgery (Hydrus microstent plus canaloplasty plus cataract surgery) works over 3 years. It looks at long-term safety and effect on eye pressure. It's for people with open-angle glaucoma who already had that specific combination of procedures.
This study tests a new gel implant (XEN63) to lower eye pressure in adults with open-angle glaucoma. It may be an option if your eye pressure remains high despite using eye drops, or if you can't tolerate the drops.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.